| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 03/06/2003 | CA2455504A1 Anti-bacterial agents based upon oxoanion binding |
| 03/05/2003 | EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound |
| 03/05/2003 | EP1286984A2 Method for the preparation of tetrahydrobenzothiepines |
| 03/05/2003 | EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1286954A2 7-substituted fused ring tetracycline compounds |
| 03/05/2003 | EP1286953A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 03/05/2003 | EP1003706B1 Cyclohexenone long-chain alcohol and medicament containing same |
| 03/05/2003 | EP0853610B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/05/2003 | CN1400972A Process for preparing piperonal |
| 03/05/2003 | CN1400969A Fused imidazolium derivatives |
| 03/05/2003 | CN1102580C Arylethenesulfonamide derivatives and drug composition containing the same |
| 03/04/2003 | US6528532 Benzenesulfonamide group |
| 03/04/2003 | US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 02/27/2003 | WO2003016298A2 Process for making a compound containing cyclic and linear carbonate groups |
| 02/27/2003 | WO2003016267A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 02/27/2003 | WO2003016265A1 Cyclic compound and ppar agonist |
| 02/27/2003 | WO2002096884A3 Substituted benzoylketones as herbicidal agents for use as plant treatment agent |
| 02/26/2003 | EP1285912A2 Process for the selective reduction of alkynic compounds |
| 02/25/2003 | US6525085 Diaryl-enynes |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | US20030036558 Useful in the treatment of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor. |
| 02/20/2003 | CA2455754A1 Amine derivatives |
| 02/19/2003 | EP1283672A1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin" |
| 02/19/2003 | EP1144360A4 A method for the synthesis of compounds of formula 1 and derivatives thereof |
| 02/19/2003 | EP0931083B1 Process for producing ecteinascidin compounds |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/18/2003 | US6521667 Calcilytic compounds |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521661 Cyclic peroxides as novel antifungal agents |
| 02/18/2003 | US6521633 Treating NIDDM with RXR agonists |
| 02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
| 02/13/2003 | WO2003011808A1 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 02/13/2003 | WO2003011799A1 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids |
| 02/13/2003 | CA2456166A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/12/2003 | EP1282595A1 Novel phenyl-propargylether derivatives |
| 02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | CN1396903A Novel compound, their preparation and use |
| 02/12/2003 | CN1396819A Novel coupler for use in oxidative hair dyeing |
| 02/12/2003 | CN1396162A Xanthiphenyl ketamine or its salt and its preparing process |
| 02/12/2003 | CN1101389C Sugar compounds, gelling agents, gelling agent compositions, process for preparation of them and gel compositions |
| 02/12/2003 | CN1101374C Synthesis of alpha-chloro or fluoro ketones |
| 02/11/2003 | US6518438 Preparation of cyclohexene carboxylate derivatives |
| 02/11/2003 | US6518326 Open chain alkoxyamine compounds and their use as polymerization regulators |
| 02/11/2003 | US6518315 Medicinal uses of phenylaikanols and derivatives |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| 02/11/2003 | CA2250391C Butadiene derivatives and process for their preparation |
| 02/06/2003 | WO2003010156A1 Method for preparing $g(a)-halogenoalkylarylketones and their halogenated intermediate products |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | US20030028048 Optically active materials |
| 02/06/2003 | US20030028039 Starting from various bicyclo(5.3.1)undec-10-ene compounds of given formula having protected hydroxyl groups; use as antitumor agents |
| 02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
| 02/06/2003 | US20030027828 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | EP1280809A1 Antitumoral ecteinascidin derivatives |
| 02/05/2003 | EP1280790A1 Use of cyclic ketals as a fragrance |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100775C Process for preparation of aromatic compounds containing heterocyclic system |
| 02/05/2003 | CN1100768C Substituted diphenyl oxazolines |
| 02/04/2003 | US6515184 The present invention relates to novel bicyclic cyclopentane-1,3- dione derivatives of the formula (I) to a process for their preparation and to their use as pesticides and herbicides. |
| 02/04/2003 | US6515150 Photoresist resin; exposure to high energy radiation; development |
| 02/04/2003 | US6515149 Acetal compound, polymer, resist composition and patterning response |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 01/30/2003 | WO2003007931A1 Sulfonamide derivatives |
| 01/30/2003 | WO2002012247A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/30/2003 | US20030023109 Low corrosive integrated process for preparing dialkyl carbonates |
| 01/30/2003 | CA2417804A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2003 | EP1278722A1 Aryl and heteroaryl sulfonates |
| 01/29/2003 | EP1192145A4 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 01/29/2003 | CN1394137A Pharmaceutical preparations containing dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease |
| 01/29/2003 | CN1100061C Hypocrellin glycoside and its preparing process |
| 01/29/2003 | CN1100055C Piperazine and piperidine compounds |
| 01/28/2003 | US6512136 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/28/2003 | US6512135 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate |
| 01/23/2003 | WO2003006453A1 Aminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006420A1 Catalytic method to convert aryl compounds to aryl amines |
| 01/23/2003 | WO2002010106A1 Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers |
| 01/23/2003 | US20030018194 New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agents |
| 01/23/2003 | US20030018070 Bisaryl compound and medicament for cancer treatment comprising the same |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018016 Cell adhesion inhibitors |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453451A1 Aminediols for the treatment of alzheimer's disease |
| 01/22/2003 | EP1071660B1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/22/2003 | EP1030835B1 Urea derivatives and their use as integrin inhibitors |
| 01/21/2003 | US6509369 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
| 01/16/2003 | WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 01/16/2003 | WO2003004458A1 New compounds |